The Latest Breaking News from Teva

U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points on Wednesday.

Teva Pharmaceuticals has recalled over 580,000 bottles of prazosin hydrochloride, a common blood pressure and PTSD medication, after tests detected a nitrosamine impurity, which the FDA warns may cause cancer with long-term exposure.

As we cling to the warm summer weather, denim shorts are a staple – and Helen’s effortlessly casual styling is perfect inspiration

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major players to seek FDA approvals for generic versions of popular medications, reshaping the competitive landscape and providing more choices for consumers.

Cushioned to the max, these trail-running sandals are comfortable underfoot and surprisingly capable on straightforward trails

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy.

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its second-quarter 2025 financial results tomorrow, July 30.

Style-conscious shoppers are increasingly turning to small-batch fashion sites to curate their look for them. As second-hand September kicks off, we meet the people making it happen

Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.